May 15, 2013 ~ Bloomberg (here) reports surgery to treat pelvic organ prolapse failed about 25 percent of the time within seven years. Reported in the May 15th Journal of the American Medical Association (JAMA) this is the longest look ever to determine how those who undergo pelvic organ prolapse (POP) repair fared in
[continue reading...]
April 28, 2013~ Never underestimate the value of love. Even when it involves a corporation. Johnson & Johnson has revealed its new campaign – For All You Love. The campaign features black and white video with sweet sleeping babies and a mother kissing goodnight in an effort to humanize the corporation. Love, “It’s the most
[continue reading...]
April 16, 2013 ~ We generally don’t discuss politics on MDND because the community of medical device-injured patients is united by the common denominator of pain and a sense of injustice. Everything else is secondary. But I’d like to share some thoughts about the movements underway in the country as I just returned from Mass
[continue reading...]
April 3, 2013 ~ Dr. Anthony Visco is Chief of Urogynecology at Duke Univ. Medical Center and President of AUGS. The American Urogynecologic Society (AUGS) was founded in 1979 and is a professional organization of 1,400 physicians and allied health professionals who care for women with pelvic floor disorders, specifically pelvic organ prolapse (POP) and
[continue reading...]
Some Highlights from the AUGS Informed Consent Toolkit, September 8-9, 2011 “At this time, AUGS does not support the routine use of transvaginal mesh for the repair of POP.” “Given the potential risks, AUGS suggest future placement of transvaginal mesh for POP repair should be judicious and be performed only by surgeons with appropriate
[continue reading...]
March 26, 2013~ Today, the American Urogynecologic Society (AUGS) issued a position statement strongly opposing restrictions that ban surgical options for the treatment of pelvic organ prolapse (POP), including transvaginal surgical mesh cleared for use by the U.S. Food and Drug Administration (FDA). The AUGS position states that it is essential for patients and their
[continue reading...]
March 8, 2013 ~ Johnson & Johnson must pay the plaintiff who brought the first DePuy metal hip implant device to trial $8.3 million in damages, a Los Angeles jury decided this afternoon. This is the first of 10,750 product liability lawsuits against J&J’s DePuy unit which makes the ASR XL hip replacement device. The
[continue reading...]
November 28, 2012 ~ Canadian women who feel they cannot have the transvaginal mesh that’s ruining their health completely removed in their country today petitioned the government to pay for transvaginal mesh removal in California. The women are from Saskatchewan and they appeared before the health minister to say that no Canadian doctor is willing
[continue reading...]
October 17, 2012 ~ Court cases filed around the country naming six mesh makers currently number 10,000 and are growing, some at a rate of 100 new cases filed a week. MDND has added up the number of lawsuits pending in federal court consolidated in multidistrict litigation (MDL) as well as those cases filed
[continue reading...]
“Application of Evidence-Based Value Analysis: Standardization of Surgical Mesh Products” In this White Paper, Winifred Hayes, a medical efficiency analyst, known as, “Your Outsourced Research Partner,” tells hospitals how to save money buying hernia mesh by being more efficient. Problem: In the case of hernia mesh, hospitals buy mesh from a limited number of
[continue reading...]
